Patents by Inventor Robert C. Booth
Robert C. Booth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10255992Abstract: A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.Type: GrantFiled: April 2, 2018Date of Patent: April 9, 2019Assignee: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20190074078Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: ApplicationFiled: September 6, 2018Publication date: March 7, 2019Applicant: Aseko, Inc.Inventors: Robert C Booth, Robert Salitsky, Andrew Rhinehart
-
Publication number: 20190019572Abstract: A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.Type: ApplicationFiled: September 18, 2018Publication date: January 17, 2019Applicant: Aseko, Inc.Inventors: Robert C. Booth, Robert E. Fischell
-
Publication number: 20190019577Abstract: A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.Type: ApplicationFiled: September 6, 2018Publication date: January 17, 2019Applicant: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20180366217Abstract: A dosing controller for administering insulin. The dosing controller includes a data processing device and non-transitory memory in communication with the data processing device. The dosing controller receives blood glucose measurements of a patient from the glucometer, receives patient information, selects a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, and executes the selected subcutaneous insulin treatment. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement.Type: ApplicationFiled: August 22, 2018Publication date: December 20, 2018Applicant: Aseko, Inc.Inventors: Robert C Booth, Harry Hebblewhite
-
Patent number: 10154298Abstract: A method of acquiring and accumulating data from a server via a network is provided. A request is transmitted for a plurality of items of data and includes at least one ingestion marker associated with the data. The at least one ingestion marker represents a last occurrence of when a change was made to the data. Data is received with a transfer protocol in response to the request. The data has at least one associated ingestion marker different than the at least one associated ingestion marker transmitted with the request. The received data and the at least one associated ingestion marker is stored in memory. The request is transmitted and the data is received and stored electronically by an electronic client device communicating with the server over the network. A system of acquiring and accumulating Electronic Program Guide (EPG) data from a web-server over a network is also disclosed.Type: GrantFiled: November 16, 2017Date of Patent: December 11, 2018Assignee: Google Technology Holdings LLCInventors: Navneeth N. Kannan, Robert C. Booth, David F. Brumbaugh
-
Patent number: 10128002Abstract: A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.Type: GrantFiled: December 27, 2017Date of Patent: November 13, 2018Assignee: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Patent number: 10102922Abstract: A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.Type: GrantFiled: April 3, 2018Date of Patent: October 16, 2018Assignee: Aseko, Inc.Inventors: Robert C. Booth, Robert E. Fischell
-
Publication number: 20180226140Abstract: A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.Type: ApplicationFiled: April 3, 2018Publication date: August 9, 2018Applicant: Aseko, Inc.Inventors: Robert C. Booth, Robert E. Fischell
-
Publication number: 20180226149Abstract: A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.Type: ApplicationFiled: April 2, 2018Publication date: August 9, 2018Applicant: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20180144818Abstract: A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.Type: ApplicationFiled: January 4, 2018Publication date: May 24, 2018Applicant: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20180128765Abstract: A method and system for optimizing insulin dosages for diabetic subjects which includes a processor for calculating basal and bolus dosages to be recommended for meal types including breakfast, lunch, dinner, snack, or at miscellaneous times. The bolus calculations are specifically directed to time periods which are taken from either pre-meal, post-meal, bedtime, mid-sleep or miscellaneous times. The processor calculates an optimized bolus for a specific time period and meal type based upon prior basal dosages, prior blood glucose doses, hypoglycemia thresholds, mid-point of target ranges, and subject insulin sensitivity factors. A display is provided to the subject for sensing the optimized insulin dosage recommended at a specific time period and for a specific meal type.Type: ApplicationFiled: January 5, 2018Publication date: May 10, 2018Applicant: Aseko, Inc.Inventor: Robert C. Booth
-
Patent number: 9965595Abstract: A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.Type: GrantFiled: November 3, 2016Date of Patent: May 8, 2018Assignee: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Patent number: 9965596Abstract: A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.Type: GrantFiled: August 15, 2017Date of Patent: May 8, 2018Assignee: Aseko, Inc.Inventors: Robert C. Booth, Robert E. Fischell
-
Publication number: 20180122505Abstract: A method of managing insulin includes receiving blood glucose measurements on a computing device from a glucometer. The blood glucose measurements are separated by a time interval. The method includes determining, by the computing device, an insulin dose rate based on the blood glucose measurements and determining a blood glucose drop rate based on the blood glucose measurements and the time interval. The method also includes determining a blood glucose percentage drop based on the blood glucose measurements. The method includes decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose drop rate is greater than a threshold drop rate, and decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose percentage drop is greater than a threshold percentage drop.Type: ApplicationFiled: December 28, 2017Publication date: May 3, 2018Applicant: Aseko, Inc.Inventors: Robert C Booth, Harry Hebblewhite
-
Publication number: 20180122504Abstract: A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.Type: ApplicationFiled: December 27, 2017Publication date: May 3, 2018Applicant: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20180122503Abstract: A method includes obtaining training data for a plurality of patients of a patient population. The training data includes training blood glucose history data including treatment doses of insulin administered by the patients of the patient population and one or more outcome attributes associated with each treatment dose. The method also includes identifying, for each patient of the patient population, one or more optimum treatment doses of insulin from the treatment doses yielding favorable outcome attributes. The method also includes receiving patient-state information for the treated patient, determining a next recommended treatment dose of insulin for the treated patient based on one or more of the identified optimum treatment doses associated with the patients of the patient population having training patient-state information similar to the patient-state information for the treated patient, and transmitting the next recommended treatment dose to a portable device associated with the treated patient.Type: ApplicationFiled: December 21, 2017Publication date: May 3, 2018Applicant: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Publication number: 20180077441Abstract: A method of acquiring and accumulating data from a server via a network is provided. A request is transmitted for a plurality of items of data and includes at least one ingestion marker associated with the data. The at least one ingestion marker represents a last occurrence of when a change was made to the data. Data is received with a transfer protocol in response to the request. The data has at least one associated ingestion marker different than the at least one associated ingestion marker transmitted with the request. The received data and the at least one associated ingestion marker is stored in memory. The request is transmitted and the data is received and stored electronically by an electronic client device communicating with the server over the network. A system of acquiring and accumulating Electronic Program Guide (EPG) data from a web-server over a network is also disclosed.Type: ApplicationFiled: November 16, 2017Publication date: March 15, 2018Inventors: Navneeth N. Kannan, Robert C. Booth, David F. Brumbaugh
-
Patent number: 9898585Abstract: A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.Type: GrantFiled: October 27, 2014Date of Patent: February 20, 2018Assignee: Aseko, Inc.Inventors: Robert C. Booth, Harry Hebblewhite
-
Patent number: 9897565Abstract: A method and system for optimizing insulin dosages for diabetic subjects which includes a processor for calculating basal and bolus dosages to be recommended for meal types including breakfast, lunch, dinner, snack, or at miscellaneous times. The bolus calculations are specifically directed to time periods which are taken from either pre-meal, post-meal, bedtime, mid-sleep or miscellaneous times. The processor calculates an optimized bolus for a specific time period and meal type based upon prior basal dosages, prior blood glucose doses, hypoglycemia thresholds, mid-point of target ranges, and subject insulin sensitivity factors. A display is provided to the subject for sensing the optimized insulin dosage recommended at a specific time period and for a specific meal type.Type: GrantFiled: September 11, 2012Date of Patent: February 20, 2018Assignee: Aseko, Inc.Inventor: Robert C. Booth